Dr. Wei Fan, director of the Tencent Medical Artificial Intelligence Laboratory, said: "We use artificial intelligence to measure the deterioration of patients with Parkinson's disease, and patients do not need to wear any sensors or equipment."
The goal of the project is to speed up the assessment of motor function, which usually took more than half an hour. And using MedopadDevelopmentThe smartphone technology hopes that patients can be evaluated within three minutes - and may not even have to go to the hospital.
As many as 10 million people worldwide are diagnosed with Parkinson's disease, and this number is likely to continue to grow as it is a common disease among the elderly. Advances in artificial intelligence technology will hopefully make it easier for doctors to prescribe treatments to alleviate symptoms.
According to the report, the system uses artificial intelligence technology, and the camera can capture the way the patient moves his hand to determine the severity of the symptoms. Currently, the research team has trained the system.
Medopad is a London-based company that develops applications and wearables to monitor patients with various diseases. The BBC pointed out that despite the company's rapid growth, Medopad's volume is still quite "mini" compared to giant companies like Tencent.
Medopad CEO Dan Vahdat said that no British company can match the services provided by Tencent as a partner. "Our goal is to affect one billion patients worldwide. To achieve this scale, we need to work with partners with international influence."
Of course, Medopad is not the only company that uses new technology to treat patients with Parkinson's disease. The BBC pointed out that two researchers at the Swiss Robotics Institute are developing a smartphone app that will require patients to perform various exercises and then use machine learning to analyze the results.